Literature DB >> 16303761

Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.

Wilfred W Raymond1, Anthony C Cruz, George H Caughey.   

Abstract

Hepatocyte growth factor (HGF) is a plasminogen-like protein with an alpha chain linked to a trypsin-like beta chain without peptidase activity. The interaction of HGF with c-met, a receptor tyrosine kinase expressed by many cells, is important in cell growth, migration, and formation of endothelial and epithelial tubes. Stimulation of c-met requires two-chain, disulfide-linked HGF. Portions of an alpha chain containing an N-terminal segment and four kringle domains (NK4) antagonize HGF activity. Until now, no physiological pathway for generating NK4 was known. Here we show that chymases, which are chymotryptic peptidases secreted by mast cells, hydrolyze HGF, thereby abolishing scatter factor activity while generating an NK4-like antagonist of HGF scatter factor activity. Thus, chymase interferes with HGF directly by destroying active protein and indirectly by generating an antagonist. The site of hydrolysis, Leu480, lies in the alpha chain on the N-terminal side of the cysteine linking the alpha and beta chains. This site appears to be specific for HGF because chymase does not hydrolyze other plasminogen-like proteins, such as macrophage-stimulating protein and plasminogen itself. Mast cell/neutrophil cathepsin G and neutrophil elastase generate similar fragments of HGF by cleaving near the chymase site. Mast cell and neutrophil peptidases are secreted during tissue injury, infection, ischemia, and allergic inflammation, where they may oppose HGF effects on epithelial repair. Thus, HGF possesses an "inactivation segment" that serves as an Achilles' heel attacked by inflammatory proteases. This work reveals a potential physiological pathway for inactivation of HGF and generation of NK4-like antagonists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303761      PMCID: PMC2271111          DOI: 10.1074/jbc.M511154200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide.

Authors:  M W Kofford; L B Schwartz; N M Schechter; D R Yager; R F Diegelmann; M F Graham
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

2.  Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.

Authors:  M Yaekashiwa; S Nakayama; K Ohnuma; T Sakai; T Abe; K Satoh; K Matsumoto; T Nakamura; T Takahashi; T Nukiwa
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

3.  HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.

Authors:  K Date; K Matsumoto; H Shimura; M Tanaka; T Nakamura
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

4.  Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation.

Authors:  S Sanker; U M Chandrasekharan; D Wilk; M J Glynias; S S Karnik; A Husain
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

5.  The HMC-1 human mast cell line expresses the hepatocyte growth factor receptor c-met.

Authors:  K Yano; K Nakao; K Sayama; K Hamasaki; Y Kato; K Nakata; N Ishii; J H Butterfield; S J Galli
Journal:  Biochem Biophys Res Commun       Date:  1997-10-29       Impact factor: 3.575

6.  Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.

Authors:  J Saarinen; N Kalkkinen; H G Welgus; P T Kovanen
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

7.  Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.

Authors:  Y Uehara; O Minowa; C Mori; K Shiota; J Kuno; T Noda; N Kitamura
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

8.  Specificity of human cathepsin G.

Authors:  J Polanowska; I Krokoszynska; H Czapinska; W Watorek; M Dadlez; J Otlewski
Journal:  Biochim Biophys Acta       Date:  1998-07-28

9.  Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.

Authors:  E Sonnenberg; D Meyer; K M Weidner; C Birchmeier
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

10.  Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.

Authors:  C A Owen; M A Campbell; P L Sannes; S S Boukedes; E J Campbell
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

View more
  13 in total

1.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  Alternative proteolytic processing of hepatocyte growth factor during wound repair.

Authors:  Nils Buchstein; Daniel Hoffmann; Hans Smola; Sabina Lang; Mats Paulsson; Catherin Niemann; Thomas Krieg; Sabine A Eming
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 3.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 4.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

5.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  How immune peptidases change specificity: cathepsin G gained tryptic function but lost efficiency during primate evolution.

Authors:  Wilfred W Raymond; Neil N Trivedi; Anastasia Makarova; Manisha Ray; Charles S Craik; George H Caughey
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

7.  The αvβ6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells.

Authors:  Kotaro Sugimoto; Makoto Kudo; Aparna Sundaram; Xin Ren; Katherine Huang; Xin Bernstein; Yanli Wang; Wilfred W Raymond; David J Erle; Magnus Abrink; George H Caughey; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

8.  Mutational tail loss is an evolutionary mechanism for liberating marapsins and other type I serine proteases from transmembrane anchors.

Authors:  Kavita Raman; Neil N Trivedi; Wilfred W Raymond; Rajkumar Ganesan; Daniel Kirchhofer; George M Verghese; Charles S Craik; Eric L Schneider; Shilpa Nimishakavi; George H Caughey
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

9.  Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.

Authors:  Karissa D McCall-Culbreath; Zhengzhi Li; Mary M Zutter
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

10.  Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.

Authors:  Katsuya Sakai; Takahiro Nakamura; Kunio Matsumoto; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.